Immunohistochemical assessment of possible anticancer effect mechanisms of 2-(6,8-dimethyl-5-nitro-4-chloroquinoline-2-yl)- 5,6,7-trichloro-1,3-tropolone in PDX models of lung cancer
Authors:
- E. F. KomarovaEKE. F. Komarova
- E. A. LukbanovaELE. A. Lukbanova
- E. A. DzhenkovaEDE. A. Dzhenkova
- A. S. GoncharovaAGA. S. Goncharova
- E. V. ZaikinaEZE. V. Zaikina
- S. V. GurovaSGS. V. Gurova
- A. V. GalinaAGA. V. Galina
- L. K. KurbanovaLKL. K. Kurbanova
- М. В. МиндарьМММ. В. Миндарь
- D. V. KhodakovaDKD. V. Khodakova
- M. S. GusarevaMGM. S. Gusareva
- M. S. ZinkovichMZM. S. Zinkovich
Open Access
- 1 February 2023
- journal article
- research article
- Published by ANO -Perspective of Oncology in South Russian Journal of Cancer
- Vol. 4 (1) , 6-13
Abstract
Purpose of the study. Evaluation of the expression of immunohistochemical tumor markers Ki-67, b-catenin, Bcl-2, P53, connexin 32 and connexin 43 when using 2-(6,8-dimethyl-5-nitro-4-chloroquinoline-2-yl)-5,6,7-trichloro-1,3-tropolone in mice with xenographs of squamous cell lung cancer.Materials and methods. Subcutaneous PDX models of human squamous cell lung cancer were created in immunodeficient BALB/c Nude mice. A fragment of the patient’s tumor (3 × 3 × 3 mm) was implanted subcutaneously in the right thigh of a previously anesthetized mouse. 200 μl of 2-(6,8-dimethyl-5-nitro-4-chloroquinoline-2-yl)-5,6,7-trichloro-1,3-tropolone was administered orally using a probe in 12 doses once every 3 days. All animals were divided into groups depending on the tropolone doses: experimental groups 2–5 with doses of 0.0055, 0.055, 0.55 and 2.75 mg/g, respectively. The control group received 1 % starch gel which was tropolone carrier. The animals were euthanized 36 days after the start of the substance administration, and the tumor tissue was isolated and prepared for the IHC study according to the standard protocol. IHC reactions were performed using antibodies for Ki-67, b-catenin, Bcl-2, P53, connexin 32 and connexin 43.Results. Higher tropolone doses were associated with decreased expression of Ki-67, b-catenin, and the Bcl-2 protein, but increased expression of the P53 protein. The dosage of tropolone and expression of connexin 43 were directly proportional.Conclusion. Immunohistochemical analysis of expression of proteins in PDX models of human squamous cell lung cancer when using 2-(6,8-dimethyl-5-nitro-4-chloroquinoline-2-yl)-5,6,7-trichloro-1,3-tropolone showed the changes indicating its antitumor efficacy and suggesting a possible mechanism of action based on the activation of apoptosis.Keywords
This publication has 17 references indexed in Scilit:
- Colchicine: A Review on Chemical Structure and Clinical UsageInfectious Disorders - Drug Targets, 2018
- Structure of 2-(benzoxazole-2-Yl)- 5,7-di(tert-butyl)-4-nitro-1,3-tropoloneJournal of Structural Chemistry, 2018
- Hinokitiol up-regulates miR-494-3p to suppress BMI1 expression and inhibits self-renewal of breast cancer stem/progenitor cellsOncotarget, 2017
- Novel tropolones induce the unfolded protein response pathway and apoptosis in multiple myeloma cellsOncotarget, 2017
- Downregulated connexin32 promotes EMT through the Wnt/β-catenin pathway by targeting Snail expression in hepatocellular carcinomaInternational Journal of Oncology, 2017
- Gap junctions and cancer: communicating for 50 yearsNature Reviews Cancer, 2016
- Anti-Microtubule Drugs2016
- Prognostic Value of Bcl-2 Expression in Squamous Cell Carcinoma of the Larynx: A Systematic ReviewThe International Journal of Biological Markers, 2015
- Synthesis and cytotoxic activity of [benzo[b][1,4]oxazepino[7,6,5-de]quinolin-2-yl]-1,3-tropolonesChemistry of Heterocyclic Compounds, 2015
- Hinokitiol Inhibits Cell Growth through Induction of S-Phase Arrest and Apoptosis in Human Colon Cancer Cells and Suppresses Tumor Growth in a Mouse Xenograft ExperimentJournal of Natural Products, 2013